89bio - ETNB Quarterly Revenue Growth

89bio (ETNB) - corporate logo

The investment potential of 89bio, Inc. (ETNB) is independent of economic cycles, as the company's success is determined by clinical trial results. Quarterly growth in commercial revenue clearly demonstrates this trend, where the value of 0.00 captures the metric level. The business foundation relies on a unique FGF21 analog for liver therapy, although research expenses are creating a temporary liquidity deficit.

ETNB 89bio Corp Quarterly Sales Growth Rate (07/04/2022 - 11/15/2025)

Metric breakdowns and analytics for 89bio (ETNB)

- current quotes and average value forecast:
Fundamental company valuation:89bio.com (ETNB)
Signature product of 89bio.com

For 89bio, Inc., operating in an undersaturated steatohepatitis therapy market, quarterly revenue growth serves as an indicator of business scaling following the completion of clinical phases. This metric calculates the percentage deviation of current revenue from the same period last year, allowing investors to assess expansion rates and timely recognize signs of market overheating that could lead to an asset price correction.

Competitors of 89bio, Inc.

ASND - Revenue Growth QoQ|MDGL: Revenue Growth QoQ|CORT: Quarterly Revenue Growth|RYTM - Quarterly Sales Growth Rate|Revenue Growth QoQ Akero Corp|Metsera Therapeutics (MTSR) - Quarterly Sales Growth Rate|Revenue Growth QoQ moonlaketx.com (MLTX)|Quarterly Sales Growth Crinetics Pharmaceuticals CRNX|Revenue Growth QoQ NewAmsterdam Pharma N.V. NAMS|Quarterly Sales Growth Rate Soleno Therapeutics Inc (SLNO)|FOLD - Revenue Growth QoQ|Revenue Change vs Previous Quarter Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Revenue Growth QoQ|Quarterly Sales Growth MiMedx Group, Inc.|Revenue Growth QoQ Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Quarterly Sales Growth Rate|Quarterly Revenue Growth MBX|Quarterly Sales Growth Altimmune, Inc. ALT|Quarterly Revenue Growth AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Quarterly Revenue Growth Rate|BIOA: Quarterly Sales Growth|Quarterly Revenue Increase BMEA (Biomea Fusion)|QNCX (quincetx.com) - Quarterly Sales Growth|Fractyl - Quarterly Revenue Increase|VTVT (vTv Therapeutics Inc) - Quarterly Revenue Growth|Agape ATP - Revenue Dynamics QoQ|Quarterly Sales Growth PLUR (Pluri Inc)|Quarterly Sales Growth Rate Synlogic Inc.|Revenue Growth QoQ Lipocine Inc. LPCN|Matinas BioPharma (MTNB) - Quarterly Revenue Growth Rate|Spruce Biosciences Inc. - Quarterly Revenue Growth|Quarterly Sales Growth Rate Galecto, Inc. GLTO|Carmell Therapeutics (CTCX) - Revenue Growth QoQ|Lumos Pharma - Quarterly Revenue Increase|ONVO (Organovo Corp) - Quarterly Revenue Growth|Radius Pharmaceuticals (RDUS) - Quarterly Sales Growth Rate